Results indicated that hydralazine improved TH-302 efficacy, albeit the effect size was small and was only moderately significant in tumors (MIA PaCa-2) that exhibit intermediate sensitivity to TH-302 as a monotherapy.
← all excerpts
Evaluation of the "steal" phenomenon on the efficacy of hypoxia activated prodrug TH-302 in pancreatic cancer.
1
—
—